Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2020 ,inter alia, to consider and approve We would like to bring to your notice that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, August 29, 2020. At the said meeting, inter-alia, the following proposal are being placed for consideration/review, for obtaining approval from the shareholders at the ensuing Annual General Meeting of the Company: Raising of funds by way of issue of equity shares through preferential issue, subject to such approval as may be required. This intimation is submitted pursuant to and in terms of Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.24-08-2020